SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 20.76 |
| Enterprise Value ($M) | -38.99 |
| Book Value ($M) | 71.80 |
| Book Value / Share | 7.44 |
| Price / Book | 0.29 |
| NCAV ($M) | 55.23 |
| NCAV / Share | 5.72 |
| Price / NCAV | 0.38 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.58 |
| Return on Assets (ROA) | -0.26 |
| Return on Equity (ROE) | -0.46 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.26 |
| Current Ratio | 3.26 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 93.16 |
| Assets | 109.73 |
| Liabilities | 37.93 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | EcoR1 Capital, LLC | 5.90 | -90.00 | |
| 13G/A | Invus Global Management, LLC | 5.90 | ||
| 13G | Artal International S.C.A. | 5.90 | 463.83 | |
| 13D | Baker Bros. Advisors Lp | 9.99 | 20.42 | |
| 13G/A | Redmile Group, LLC | 1.10 | -80.52 | |
| 13G/A | Gilead Sciences Inc | 19.40 | 398.99 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 24,015 | 112,073 | 21.43 | |
| 12,351 | 91,999 | 13.43 | |
| 39,157 | 163,512 | 23.95 | |
| 14,910 | 55,860 | 26.69 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| GTBP – GT Biopharma, Inc. | GYRE – Gyre Therapeutics, Inc. |
| HEPA – Hepion Pharmaceuticals, Inc. | HOTH – Hoth Therapeutics, Inc. |
| HRTX – Heron Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io